Neumirna Therapeutics Appoints Ellen K. Donnelly as Chief Executive Officer
COPENHAGEN, Denmark–(BUSINESS WIRE)– Neumirna Therapeutics, a biotechnology company developing RNA-based therapies for neurological diseases, today announced the appointment of Ellen K. Donnelly, Ph.D. as Chief...